Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today provides a business update highlighting the Company's recent achievements in strengthening its product franchise and ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...
Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...
Until about five years ago, scientists believed the pregnancy hormone, human chorionic gonadotropin (hCG), was the culprit.
A study of more than 5,000 pages of agency documents on mifepristone over 12 years found that agency leaders almost always ...
Dax Shepard agrees with fans who think he looks like he’s had plastic surgery. Shepard, 51, said during the Monday, January 12, episode of his “Armchair Expert” podcast that he realized how “different ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
Novocure exits 2025 having achieved record annual revenue, providing the financial strength to execute on the exciting growth opportunities we have in 2026,” said Frank Leonard, CEO, Novocure. “We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback